Targeting caspases in cancer therapeutics

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Apoptosis (programmed cell death) is vital for maintaining homeostasis and preventing uncontrolled cell proliferation.
• Loss of apoptosis is a hallmark of cancer, contributing to tumor development and progression.
• The caspase family of proteases plays a central role in executing apoptosis.

Purpose of the Study:

• To review the role of caspases in apoptosis and cancer.
• To discuss strategies for reactivating caspase-mediated apoptosis for cancer therapy.
• To explore the potential of targeting caspases to overcome therapeutic resistance.

Main Methods:

• Literature review of studies on apoptosis, caspases, and cancer therapeutics.
• Analysis of preclinical and clinical data on apoptosis-inducing agents.
• Discussion of molecular mechanisms underlying caspase activation and inhibition.

Main Results:

• Caspase activation is essential for both intrinsic and extrinsic apoptotic pathways.
• Apoptosis inhibitors can restore caspase activity, leading to cancer cell death.
• Upregulating caspases can sensitize resistant tumors to radiation and chemotherapy.

Conclusions:

• Reinstating caspase-mediated apoptosis is a viable therapeutic strategy for cancer.
• Targeting caspases offers a platform for developing potent and selective anticancer drugs.
• Understanding caspase function is key to overcoming treatment resistance in tumors.